Business  
/
 
Sectors  
/
 
Health & Pharma
Fiona Reddan

Fiona Reddan

Fiona Reddan is a regular contributor to The Irish Times, covering business, innovation and technology, personal finance and property topics. She writes for the weekly “Your Money” personal finance pages and also has a bi-monthly column on house-hunting “On the Move” in Thursday's property supplement.

She is author of “Irelands IFSC: a Story of Global Financial Success”, published in 2008 by Mercier Press, and has been a commentator on business and economic issues on RTE's The Pat Kenny Show and Today FM’s Sunday Business Show, amongst others.

International Monetary Fund first deputy managing director and acting chair David Lipton: “Strong policy implementation and timely delivery on European pledges to enhance programme sustainability remain key.” Photograph: Reuters/Yuya Shino
IMF warns that Ireland’s economic recovery is still volatile

Risks to debt sustainability remain, says IMF acting chair

Denmark’s Financial Services Authority noted that Ireland had a “significant effect” on Danske Bank’s risk weighting, resulting in a total group-level risk weight of 36 per cent, of which Ireland accounted for 4 per cent.
Danske Bank told Irish arm adds to risk

Danish regulator finds Irish operation has ‘significant effect’ on bank’s profile

INM shareholders approve sale of South African assets

Restructuring resolution also passed

Paddy Power has won an appeal to open a new shop in East Ham in London. (Photo: Julien Behal/PA Wire)
Paddy Power wins appeal over London outlet

Gambling group is granted licence to open shop in east London

A pedestrian walks past a brokerage in Tokyo where stocks fluctuations have affected investors in recent times. Photograph: Reuters/Yuya Shino
Does gut instinct betray us when it comes to investing?

Understanding how your personality affects the financial choices you make can save you a significant amount of money

Joan Burton, Minister for Social Protection, pictured at the launch of the report with chairperson of the Board, Jane Williams (l) and chief executive Brendan Kennedy (r).
Pensions Board expresses concern over defined benefit schemes

Annual report for 2012 shows decrease of more than 7,000 in DB schemes

Royalty Pharma’s $6.7 billion offer for Irish pharmacuetical firm Elan has now lapsed
Stalemate for Royalty Pharma’s bid for Elan as shareholders approve buyback programme

US pharma firm invited to bring forward “a new offer” following egm

United Drug has announced changes to its board of directors. Pictured above is its City West operation.(Photograph: DAVE MEEHAN)
New director at United Drug

London listed pharmaceutical firm announces directorate changes

Irish investors have lost faith in official company reports, according to a new survey from the ACCA ( Photographer: Maurice Tsai/Bloomberg News)
Investors have lost their trust in company reports

Almost 50 per cent of investors surveyed by ACCA said that an annual report is of “no use”

More articles

Health Pharma

Royalty Pharma co-founder and chairman Rory Biggs. The US-based company has withdrawn its hostile bid for Irish drugmaker Elan. Royalty Pharma drops hostile bid for Elan
Elan chairman Robert Ingram at the company’s EGM in Dublin today. Photograph: Aidan Crawley Elan loses shareholder support but Royalty bid may also perish
Royalty Pharma’s $6.7 billion offer for Irish pharmacuetical firm Elan has now lapsed Stalemate for Royalty Pharma’s bid for Elan as shareholders approve buyback programme